Overview
News
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Total raised
$21.4M
7 rounds on record
Latest round
$1.9M
Convertible Note · Dec 2021 · 4 yr ago
Team
51-200
employees, estimated range
Grants
$2.1M
4 grants · CORDIS
Backers
1
Port Folia
The money's age
Long since its last round
57 months since the last round · not hiring
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Jun 28, 2023 Recognition OtoNexus Medical Technologies Honored as a Top 100 Best Place to Work in Washington State · counton2.com Apr 4, 2023 Board appointment OtoNexus Medical Technologies Welcomes Chris Rivera to its Board of Directors · PRNewswire Oct 20, 2022 Took on debt financing $12.9M · SEC Form D Dec 30, 2021 Raised a round Convertible Note $1.9M · SEC Form D Mar 15, 2019 Won a grant $718k · CORDIS Jul 1, 2017 Won a grant $999k · CORDIS Jul 1, 2017 Won a grant $225k · CORDIS Sep 1, 2016 Won a grant $148k · CORDIS
Funding rounds
RoundDateAmountInvestorsSource
Debt Financing Oct 2022 $12.9M — SEC Form D
Convertible Note Dec 2021 $1.9M — SEC Form D
Grant Mar 2019 $718k — CORDIS
Venture round Dec 2018 $19.5M — SEC Form D
Grant Jul 2017 $225k — CORDIS
Grant Jul 2017 $999k — CORDIS
Grant Sep 2016 $148k — CORDIS
Registers and programsofficial lists and records that name the company
Legal entity OtoNexus Medical Technologies, Inc. SEC Form D
Founders and leadersfrom filings, registers and the company's site
Caitlin CameronExecutive Officer, DirectorSEC Form D
George GatesExecutive Officer, DirectorSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Similar startupsby what they do, their industry and backers
Arrowsmith Inc. is a research-driven biotech focused on bringing next-generation phage therapy into clinical use for patients suffering…
Our Mission and Innovation We are a biotechnology pioneer dedicated to solving one of the greatest challenges in modern medicine: the…
Resistell51-200 employees
Welcome to Resistell, where we harness cutting-edge nanomotion technology to provide the fastest, most accurate ultra-rapid antibiotic…
smartbax11-50 employees
Smartbax is dedicated to developing innovative antibiotics to combat the rising threat of multi-drug-resistant bacteria and protect global…
Gamgee is developing personalised mRNA vaccines as a cancer treatment for dogs, built from each dog’s tumour. See how it works with vets…
Procarta Biosystems Ltd aims to revolutionise the treatment of serious and life-threatening infection through the development of innovative…

Overview

OtoNexus Medical Technologies is developing an AI-assisted ultrasound otoscope intended to improve the identification and management of middle ear infections by reducing diagnostic uncertainty and supporting responsible antibiotic use.

News

News YahooFinance 1 year ago
OtoNexus Medical Technologies Ranks #4 Among Micro Companies on Puget Sound Business Journal
OtoNexus Medical Technologies has been named to Puget Sound Business Journal
Read more
Report
Press release PRNewswire 3 years ago
OtoNexus Medical Technologies Accepted into Prestigious Pediatric Medical Device Accelerator, CTIP
/PRNewswire/ -- OtoNexus Medical Technologies Inc., the innovators behind the first ultrasound-based medical device for the instant, accurate assessment of...
Read more
Report
Press release PRNewswire 3 years ago
OtoNexus Medical Technologies Welcomes Chris Rivera to its Board of Directors
/PRNewswire/ -- OtoNexus Medical Technologies, Inc. is pleased to announce the appointment of Chris Rivera to its Board of Directors. Mr. Rivera has a...
Read more
Report
News YahooFinance 10 years ago
SNS FiRe Conference Names OtoNexus Medical Technologies a 2016 FiReStarter Company
Strategic News Service has selected OtoNexus Medical Technologies as a 2016 FiReStarter company to be featured at the 14th annual Future in Review conference. FiRe 2016 will take place September 27-30, ...
Read more
Report
Puget Sound Business Journal
OtoNexus Medical Technologies is honored to have received awards and recognition from Keiretsu Capital (Most Valued Company), Keiretsu Forum MidAtlantic (Most Valued Company), Keiretsu Forum Northwest (Most Valued Company), Red Herring (Top 100 North Amer
Read more
Report

People

Caitlin Cameron
Executive Officer, Director
George Gates
Executive Officer, Director
Harris Brody
Director
Marion Foote
Director
Mark Moehring
Director
Rhonda Rhyne
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Bellevue United States
HQ
50-200 est. staff

Financials

Total raised
$36.4M
Latest round
Debt Financing
Funding rounds
7
Funding rounds
Round Announced Amount
Debt Financing 2022 $12.9M Details
Convertible Note 2021 $1.9M Details
Grant 2019 $718k Details
Venture - Series Unknown 2018 $19.5M Details
Grant 2017 $225k Details
Grant 2017 $999k Details
Grant 2016 $148k Details